Bryan Linggi

Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor–neutralizing therapy in patients with inflammatory bowel disease

Nathaniel R. West, Ahmed N. Hegazy, Benjamin M. J. Owens et al. · Nature Medicine · 2017 · 805 citations · Full text

Medicine, Immunology, Oncology +17

ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors

Bart Lutterbach, Jennifer J. Westendorf, Bryan Linggi et al. · Molecular and Cellular Biology · 1998 · 440 citations · Full text

Life Sciences, Molecular Biology, Oncology +15

Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis

Birgit Schoeberl, Emily A. Pace, Jonathan B. Fitzgerald et al. · Science Signaling · 2009 · 368 citations

Life Sciences, Cell Biology, Molecular Biology +17

The t(8;21) fusion protein, AML1–ETO, specifically represses the transcription of the p14ARF tumor suppressor in acute myeloid leukemia

Bryan Linggi, Carsten Müller‐Tidow, Louis van de Locht et al. · Nature Medicine · 2002 · 257 citations

Medicine, Molecular Biology, Molecular Genetics +14

A Mechanism of Repression by Acute Myeloid Leukemia-1, the Target of Multiple Chromosomal Translocations in Acute Leukemia

Bart Lutterbach, Jennifer J. Westendorf, Bryan Linggi et al. · Journal of Biological Chemistry · 2000 · 244 citations · Full text

Life Sciences, Genetics, Molecular Biology +16